Developing an ontology for representing the domain knowledge specific to non-pharmacological treatment for agitation in dementia | Western Sydney University ResearchDirect
![Frontiers | Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions Frontiers | Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions](https://www.frontiersin.org/files/Articles/644317/fneur-12-644317-HTML/image_m/fneur-12-644317-g001.jpg)
Frontiers | Agitation and Dementia: Prevention and Treatment Strategies in Acute and Chronic Conditions
![Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing - ScienceDirect Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0753332222004024-ga1.jpg)
Pain and agitation treatment in severe dementia patients: The need for Italian Mobilization–Observation–Behavior–Intensity–Dementia (I-MOBID2) pain scale translation, adaptation and validation with psychometric testing - ScienceDirect
![Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis - Kongpakwattana - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis - Kongpakwattana - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/fe08363e-8813-4b4a-9b3b-efc7ff32b4a1/bcp13604-fig-0001-m.jpg)
Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis - Kongpakwattana - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library
![Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials - ScienceDirect Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1064748119305214-gr1.jpg)
Efficacy and Safety of Brexpiprazole for the Treatment of Agitation in Alzheimer's Dementia: Two 12-Week, Randomized, Double-Blind, Placebo-Controlled Trials - ScienceDirect
![Non-pharmacologic Interventions for Agitation and Aggression in Dementia | Effective Health Care (EHC) Program Non-pharmacologic Interventions for Agitation and Aggression in Dementia | Effective Health Care (EHC) Program](https://effectivehealthcare.ahrq.gov/sites/default/files/af-nonpharm-dementia.png)
Non-pharmacologic Interventions for Agitation and Aggression in Dementia | Effective Health Care (EHC) Program
![Figure 1 from Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia | Semantic Scholar Figure 1 from Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/e9cfa55d0dadc15bbdc85d688cbd6521218b9a2b/3-Figure1-1.png)
Figure 1 from Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia | Semantic Scholar
![Emerging Perspectives in the Management of Agitation in Alzheimer's Disease and Patients with Dementia - touchNEUROLOGY Emerging Perspectives in the Management of Agitation in Alzheimer's Disease and Patients with Dementia - touchNEUROLOGY](https://touchneurology.com/wp-content/uploads/sites/3/2022/06/Table-333.png)
Emerging Perspectives in the Management of Agitation in Alzheimer's Disease and Patients with Dementia - touchNEUROLOGY
![Table 2 : Commonly Prescribed Drugs for Agitation and Apathy in Dementia , and Dosage Guidelines for Older Adults | Semantic Scholar Table 2 : Commonly Prescribed Drugs for Agitation and Apathy in Dementia , and Dosage Guidelines for Older Adults | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/164b83639f130601ade3b605ba9f6564bb9d8304/2-Table1-1.png)
Table 2 : Commonly Prescribed Drugs for Agitation and Apathy in Dementia , and Dosage Guidelines for Older Adults | Semantic Scholar
![Approaches to the management of agitation in dementia (reprinted from... | Download Scientific Diagram Approaches to the management of agitation in dementia (reprinted from... | Download Scientific Diagram](https://www.researchgate.net/publication/333983595/figure/fig1/AS:962686833672204@1606533835686/Approaches-to-the-management-of-agitation-in-dementia-reprinted-from-The-Lancet-volume.png)
Approaches to the management of agitation in dementia (reprinted from... | Download Scientific Diagram
![First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum](https://psychiatryeducationforum.com/wp-content/uploads/2023/05/Auvelity-1.png)
First FDA Approved Medication for Agitation Associated with Alzheimer's Dementia – Psychiatry Education Forum
![Emerging Perspectives in the Management of Agitation in Alzheimer's Disease and Patients with Dementia - touchNEUROLOGY Emerging Perspectives in the Management of Agitation in Alzheimer's Disease and Patients with Dementia - touchNEUROLOGY](https://touchneurology.com/wp-content/uploads/sites/3/2022/06/Table-222.png)
Emerging Perspectives in the Management of Agitation in Alzheimer's Disease and Patients with Dementia - touchNEUROLOGY
![Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial - The Lancet Psychiatry Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial - The Lancet Psychiatry](https://www.thelancet.com/cms/asset/69db006f-30a4-453c-b8a4-ea37e37ca33e/gr1.gif)
Clinical and cost-effectiveness of the Managing Agitation and Raising Quality of Life (MARQUE) intervention for agitation in people with dementia in care homes: a single-blind, cluster-randomised controlled trial - The Lancet Psychiatry
![Differential diagnoses in case of dementia-related agitation and other... | Download Scientific Diagram Differential diagnoses in case of dementia-related agitation and other... | Download Scientific Diagram](https://www.researchgate.net/publication/350924638/figure/tbl1/AS:1019781771702283@1620146329850/Differential-diagnoses-in-case-of-dementia-related-agitation-and-other-conditions.png)